Clinical Trials Logo

Filter by:
NCT ID: NCT05802290 Completed - Clinical trials for Squamous Cell Carcinoma of Head and Neck

NIVolumab in Subjects With Recurrent or Metastatic Platinum-refrACTORy SCCHN

NIVACTOR
Start date: November 27, 2017
Phase: Phase 3
Study type: Interventional

Subjects will receive treatment with nivolumab monotherapy at 240mg flat dose as a 30 minute IV infusion on Day 1 of a treatment cycle every 2 weeks (14 days) until confirmed progression of disease, unacceptable toxicity, death or withdrawal of consent. This study is designed to better evaluate the safety profile of nivolumab in a large series of patients with Recurrent or Metastatic (R/M) Squamous Cell Carcinoma of the Head and Neck. The primary endpoint of this study is the incidence of high-grade (CTCAE v 4.03 Grade 3 or higher), treatment-related, select adverse events.

NCT ID: NCT05801315 Completed - Clinical trials for Peri-implant Mucositis

Non-surgical Treatment of Peri-implant Mucositis: FMUD vs FMUD and Air-Flow Master Piezon®

Start date: March 1, 2020
Phase: N/A
Study type: Interventional

The aim of the present study is to evaluate the adjunctive effect of glycine-powder air-polishing (GPAP) to full-mouth ultrasonic debridement (Fm-UD) in the treatment of peri-implant mucositis, and to determine the predictive role of implant and patient-level variables for disease resolution. Both treatments are described in the literature, but few studies are available on their comparison.

NCT ID: NCT05800613 Completed - Pediatric ALL Clinical Trials

Management of Ovarian Masses in Pediatric Patients: an Italian Survey

OvaMa-PEDs
Start date: June 16, 2022
Phase:
Study type: Observational

Objectives: The International Ovarian Tumor Analysis (IOTA) provides a specific terminology for adult ovarian masses, while, currently, there is no systematic classification for preoperative assessment of adnexal lesions in childhood and adolescence. This study aims to survey Italian pediatric surgeons to evaluate ovarian masses' management (from diagnosis to treatment) in patients aged 1-18. Methods: A 27-question survey was distributed. It consisted of questions regarding the management and use of ultrasound and IOTA terminology in diagnosing ovarian masses in childhood and adolescence, in emergency regimes and in planned surgeries.

NCT ID: NCT05800288 Completed - Propofol Clinical Trials

Effect of Midazolam Bolus on Eleveld and Schnider TCI (Target Controlled Infusion) Models

TCI
Start date: March 30, 2023
Phase:
Study type: Observational

No trials have evaluated the effect of a Midazolam bolus (routinely used for premedication before general anesthesia) on the Concnetration at the effector site of Propofol (CeP) of Eleveld and Schnider TCI models, routinely used for general anesthesia delivery.

NCT ID: NCT05799729 Completed - Ketamine Clinical Trials

Effect of Ketamine Infusion on BIS Values

Start date: April 1, 2023
Phase:
Study type: Observational

Aim of this trial is to define if Concentration at the effector site (Ce) of Ketamine, during a continuous infusion and calculated with DOMINO model infusion pump are correlated with Bispectral Index BIS values during general anaesthesia for breast surgery.

NCT ID: NCT05798689 Completed - Probiotics Clinical Trials

Use of a Selected Mixture of Probiotic Strains for Degrading Gluten During Digestion

Start date: October 1, 2020
Phase: N/A
Study type: Interventional

Gluten intake spreads worldwide, being the major food protein consumed in the Western diets (up to 20 g gluten/d). But gluten has unique and unusual features. It resists the complete luminal digestion by gastric, pancreatic and intestinal brush border enzymes, and is susceptible to post-translational modification (deamidation) by mucosal transglutaminases. Apart from partial digestion, gluten per se has a negative impact on a consistent part of the worldwide population, which mainly results in the manifestations of celiac disease (CD) or other gluten-related disorders. This study will enable to test in vivo a novel multi-species probiotic that in vitro has proven to degrade gluten to non-immunotoxic peptides.

NCT ID: NCT05797571 Completed - Informal Caregivers Clinical Trials

SOSteniamoci: Stakeholders' Survey

Start date: January 15, 2022
Phase:
Study type: Observational

Informal care is defined as the unpaid care provided to an older, frail, or ill person, by a person such as a spouse, a parent, a child, another relative, a neighbor, or a friend. This phenomenon may lead to stress, burden, and decreased informal caregivers' quality of life. Since lack of time, distance from services, and financial strains make the provision of psychological interventions to informal caregivers often challenging, Internet-based (self-help) programs might represent a viable solution to promote their emotional well-being. Still, despite the proven benefits of internet-based intervention, no available programs for informal caregivers are available for the Italian population. Nevertheless, planning and developing an online intervention, involving possible stakeholders (caregivers), might facilitate the understanding and dissemination of, willingness to use, and success of the future intervention. Thus, the goal of the current study is to assess Italian stakeholders' knowledge about, awareness of, attitudes towards, willingness to participate and use, and expected barriers to internet-based interventions.

NCT ID: NCT05796128 Completed - Clinical trials for Respiratory Distress Syndrome, Newborn

NIPPV vs.nCPAP During LISA Procedure

NIPAL
Start date: October 1, 2020
Phase: N/A
Study type: Interventional

The goal of this randomized controlled study is to compare the efficacy of using NIPPV versus NCPAP during the LISA procedure in very preterm infants. The main question it aims to answer is: • Does NIPPV during the LISA procedure decrease the need for a second dose of surfactant or the need of mechanical ventilation during the first 72 hours of life in comparison with NCPAP? Infants with gestational age between 25+0 and 31+6 weeks of gestation with RDS who do not require VM and treated with NCPAP and FiO2 >0.30 within the first 6 hours of life who received the first dose of caffeine will be eligible for enrollment in the study Participants will be randomized to receive surfactant with conventional LISA procedure, i.e. performed during NCPAP, or with LISA procedure performed during NIPPV.

NCT ID: NCT05795985 Completed - Inflammation Clinical Trials

Role of Faecal Calprotectin in Patients With Abdominal Pain

Start date: July 1, 2021
Phase:
Study type: Observational

The evaluation of patients with abdominal pain is a challenge for the emergency physician and the selection of patients for second-level radiological examinations or endoscopic procedures is not always easy to perform. Faecal calprotectin could be a useful diagnostic marker to distinguish between "organic" or "functional" form and its determination could be helpful to select patients for further examinations, in the context of emergency setting.

NCT ID: NCT05795803 Completed - Clinical trials for Somatic Symptom Disorder

Effects of COVID-19 Forced Isolation Context on Adolescents With and Without Somatic Symptom Disorder

Start date: April 1, 2020
Phase:
Study type: Observational

The purpose of this study is to evaluate whether a forced isolation context (such provided by the ongoing Covid-19 pandemic restrictive measures) could reduce the burden of somatic symptoms among a group of patients with Somatic Symptom Disorder (SSD). Secondary objective is to assess if a reduction in terms of depression tendency and anxiety occurs in this specific population and which are the effect of such a context among a group of adolescents without SSD. We want to compare these results with data obtained at the end of the pandemic.